I agree with everyone here - there is a no real PR in Australia...

I agree with everyone here - there is a no real PR in Australia about TD1. I am still surprised that there is no push for TD1 technology as a gateway for education and health - whether it is in children wards; mental & psychiatric assessment in schools; early to teens childhood. Especially, TD1 says they're delivering diagnostic and therapeutic solutions for cognitive function and behaviour. In July 2021, TD1 was granted its first Australian patent by IP Australia. This patent covers TALi TRAIN and TALi DETECT. This technology should be pushed by media/PR - as an awareness for business and customers. I would not buy until there is real PR or Gov contract with the technology - otherwise you will be waiting for FDA approval which sounds like it will be later 2023...especially if it will create a multi-decade annuity revenue stream in the US market as no additional regulatory approvals in the US will be required etc. I will still follow this...and comment along the way - RG.